Clinical Pharmacology &Therapeutics, EarlyView.From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park +22 more
wiley +1 more source
Erratum: Do predictors of abstinence change in the medium- and long-term follow-up of smokers who have quit smoking? A prospective cohort study. [PDF]
Tob Prev CessatEuropean Publishing Production Team.
europepmc +1 more source
Does screening of COPD deter smokers with normal lung function to quit smoking? [PDF]
, 2010 Daniel Kotz, Onno C. P. van Schayck
openalex +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Pregabalin and duloxetine are widely prescribed non‐opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety.
Sachalee Campbell +11 more
wiley +1 more source
Socioeconomic Inequalities in Intention to Quit Smoking Plan Among Korean Adults, 2016-2021. [PDF]
Tob Use InsightsPark S +6 more
europepmc +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Cinnamon (Cinnamomum spp.) is used as a culinary spice and dietary supplement. A major constituent, cinnamaldehyde, was previously shown to inactivate cytochrome P450 (CYP) 2A6 in vitro. A mechanistic static model predicted an ~5‐fold increase in the AUC of the CYP2A6 substrates nicotine and letrozole.
Aiden‐Hung P. Nguyen +8 more
wiley +1 more source
Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading. [PDF]
Nicotine Tob ResJohnstone S +11 more
europepmc +1 more source
Mental health, smoking, harm reduction and quit attempts – a population survey in England [PDF]
, 2020 Leonie S. Brose +3 more
openalex +1 more source
The role of Rho GTPases in facial morphogenesis
Developmental Dynamics, EarlyView.The role of small GTPases, RHOA, RAC1, and CDC42 and pathway mediators is reviewed in the context of embryonic facial development. Lip fusion requires cytoskeletal remodeling during morphogenesis of the facial processes and during lip fusion. Fnm, frontonasal mass; lnp, lateral nasal process; mnp, medial nasal process; mxp, maxillary process; np, nasal
Isra Ibrahim, Joy M. Richman
wiley +1 more source
Do predictors of abstinence change in the medium- and long-term follow-up of smokers who have quit smoking? A prospective cohort study. [PDF]
Tob Prev Cessatde Granda-Orive JI +19 more
europepmc +1 more source